512 related articles for article (PubMed ID: 19743625)
1. Rapid killing of M. leprae by moxifloxacin in two patients with lepromatous leprosy.
Pardillo FE; Burgos J; Fajardo TT; Dela Crux E; Abalos RM; Paredes RM; Andaya CE; Gelber RH
Lepr Rev; 2009 Jun; 80(2):205-9. PubMed ID: 19743625
[TBL] [Abstract][Full Text] [Related]
2. The effect of corticosteroids usage on bacterial killing, clearance and nerve damage in leprosy; part 3--Study of two comparable groups of 100 multibacillary (MB) patients each, treated with MDT + steroids vs. MDT alone, assessed at 6 months post-release from 12 months MDT.
Shetty VP; Khambati FA; Ghate SD; Capadia GD; Pai VV; Ganapati R
Lepr Rev; 2010 Mar; 81(1):41-58. PubMed ID: 20496569
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of minocycline in single dose and at 100 mg twice daily for lepromatous leprosy.
Gelber RH; Murray LP; Siu P; Tsang M; Rea TH
Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):568-73. PubMed ID: 7868955
[TBL] [Abstract][Full Text] [Related]
4. Viability of Mycobacterium leprae in lepromatous patients after five years of dapsone monotherapy supplemented with two years of multidrug therapy.
Sivaprasad N; Snehalatha S; Lobo D; Aschhoff M; Job CK
Indian J Lepr; 1995; 67(4):427-33. PubMed ID: 8849919
[TBL] [Abstract][Full Text] [Related]
5. A clinical trial of ethionamide and prothionamide for treatment of lepromatous leprosy.
Fajardo TT; Guinto RS; Cellona RV; Abalos RM; Dela Cruz EC; Gelber RH
Am J Trop Med Hyg; 2006 Mar; 74(3):457-61. PubMed ID: 16525107
[TBL] [Abstract][Full Text] [Related]
6. Powerful bactericidal activity of moxifloxacin in human leprosy.
Pardillo FE; Burgos J; Fajardo TT; Dela Cruz E; Abalos RM; Paredes RM; Andaya CE; Gelber RH
Antimicrob Agents Chemother; 2008 Sep; 52(9):3113-7. PubMed ID: 18573938
[TBL] [Abstract][Full Text] [Related]
7. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy.
Narang T; Kaur I; Kumar B; Radotra BD; Dogra S
Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):105-14. PubMed ID: 16830653
[TBL] [Abstract][Full Text] [Related]
8. Are viable Mycobacterium leprae present in lepromatous patients after completion of 12 months' and 24 months' multi-drug therapy?
Ebenezer GJ; Daniel S; Norman G; Daniel E; Job CK
Indian J Lepr; 2004; 76(3):199-206. PubMed ID: 15835604
[TBL] [Abstract][Full Text] [Related]
9. A clinical trial of pefloxacin and ofloxacin in lepromatous leprosy.
Fajardo TT; Villahermosa LG; Cruz EC; Cellona RV; Balagon MV; Abalos RM; Gelber RH
Lepr Rev; 2004 Dec; 75(4):389-97. PubMed ID: 15685736
[TBL] [Abstract][Full Text] [Related]
10. Two microbiological relapses in a patient with lepromatous leprosy.
Chakma JK; Girdhar A; Natrajan M; Kumar A; Girdhar BK
Lepr Rev; 2008 Sep; 79(3):331-4. PubMed ID: 19009984
[TBL] [Abstract][Full Text] [Related]
11. Clinical trial of pefloxacin and ofloxacin in the treatment of lepromatous leprosy.
Grosset JH; Ji BH; Guelpa-Lauras CC; Perani EG; N'Deli LN
Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):281-95. PubMed ID: 2198315
[TBL] [Abstract][Full Text] [Related]
12. The activity of rifabutin against Mycobacterium leprae.
Yoder LJ; Jacobson RR; Hastings RC
Lepr Rev; 1991 Sep; 62(3):280-7. PubMed ID: 1665534
[TBL] [Abstract][Full Text] [Related]
13. Activity of two doses of rifampin against Mycobacterium leprae.
Husser JA; Traore I; Daumerie D
Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):359-64. PubMed ID: 7963907
[TBL] [Abstract][Full Text] [Related]
14. Intranasal administration of fusidic acid cream in leprosy.
Mahajan PM; Jadhav VH; Jogaikar DG; Mehta JM
Indian J Lepr; 2000; 72(4):451-5. PubMed ID: 11212479
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of pefloxacin in the treatment of lepromatous leprosy.
N'Deli L; Guelpa-Lauras CC; Perani EG; Grosset JH
Int J Lepr Other Mycobact Dis; 1990 Mar; 58(1):12-8. PubMed ID: 2181041
[TBL] [Abstract][Full Text] [Related]
16. Relapses during long-term follow up with drug-susceptible M. leprae among multibacillary leprosy patients treated with multidrug therapy regimens; case reports.
Thomas A; Hari L; Nagarajan M; Prabhakar R
Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):391-4. PubMed ID: 7594922
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesion.
Majumder V; Saha B; Hajra SK; Biswas SK; Saha K
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):283-90. PubMed ID: 11221091
[TBL] [Abstract][Full Text] [Related]
18. Pattern of bacillary clearance in multibacillary leprosy patients with multidrug therapy.
Kumar A; Girdhar A; Girdhar BK
Acta Leprol; 2003; 12(3):123-8. PubMed ID: 15040703
[TBL] [Abstract][Full Text] [Related]
19. Viability and drug susceptibility testing of M. leprae using mouse footpad in 37 relapse cases of leprosy.
Shetty VP; Wakade AV; Ghate S; Pai VV; Ganapati R; Antia NH
Int J Lepr Other Mycobact Dis; 2003 Sep; 71(3):210-7. PubMed ID: 14608816
[TBL] [Abstract][Full Text] [Related]
20. Minocycline in lepromatous leprosy.
Fajardo TT; Villahermosa LG; dela Cruz EC; Abalos RM; Franzblau SG; Walsh GP
Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):8-17. PubMed ID: 7730723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
